Profund Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.07M Sell
4,138
-61
-1% -$29.3K 0.06% 191
2026
Q1
$2.06M Sell
4,199
-1,914
-31% -$1.04M 0.08% 194
2025
Q4
$3.54M Buy
6,113
+1,236
+25% +$699K 0.11% 125
2025
Q3
$2.37M Buy
4,877
+56
+1% +$26.1K 0.08% 167
2025
Q2
$1.95M Sell
4,821
-415
-8% -$174K 0.07% 191
2025
Q1
$2.61M Sell
5,236
-149
-3% -$80.7K 0.11% 140
2024
Q4
$2.8M Sell
5,385
-748
-12% -$411K 0.1% 134
2024
Q3
$3.79M Buy
6,133
+187
+3% +$111K 0.14% 106
2024
Q2
$3.29M Sell
5,946
-105
-2% -$60.2K 0.12% 124
2024
Q1
$3.52M Sell
6,051
-281
-4% -$158K 0.14% 112
2023
Q4
$3.36M Buy
6,332
+355
+6% +$172K 0.14% 118
2023
Q3
$3.03M Sell
5,977
-170
-3% -$90.6K 0.17% 106
2023
Q2
$3.21M Buy
6,147
+47
+0.8% +$25.4K 0.17% 88
2023
Q1
$3.52M Sell
6,100
-54
-0.9% -$30.4K 0.22% 77
2022
Q4
$3.39M Sell
6,154
-103
-2% -$54.6K 0.22% 82
2022
Q3
$3.17M Sell
6,257
-318
-5% -$178K 0.23% 81
2022
Q2
$3.57M Sell
6,575
-1,000
-13% -$550K 0.23% 80
2022
Q1
$4.47M Sell
7,575
-1,560
-17% -$896K 0.19% 87
2021
Q4
$6.09M Buy
9,135
+797
+10% +$498K 0.2% 80
2021
Q3
$4.76M Buy
8,338
+213
+3% +$117K 0.16% 107
2021
Q2
$4.1M Buy
8,125
+83
+1% +$39.2K 0.14% 123
2021
Q1
$3.67M Sell
8,042
-1,235
-13% -$589K 0.14% 124
2020
Q4
$4.32M Sell
9,277
-137
-1% -$64.2K 0.19% 96
2020
Q3
$4.16M Sell
9,414
-2,396
-20% -$990K 0.21% 84
2020
Q2
$4.28M Buy
11,810
+2,471
+26% +$828K 0.24% 79
2020
Q1
$2.65M Sell
9,339
-1,891
-17% -$596K 0.2% 95
2019
Q4
$3.65M Buy
11,230
+824
+8% +$250K 0.16% 114
2019
Q3
$3.03M Sell
10,406
-1,402
-12% -$401K 0.15% 122
2019
Q2
$3.47M Sell
11,808
-3,166
-21% -$872K 0.16% 115
2019
Q1
$4.1M Buy
14,974
+1,214
+9% +$302K 0.2% 95
2018
Q4
$3.08M Sell
13,760
-2,869
-17% -$673K 0.19% 102
2018
Q3
$4.06M Buy
16,629
+4,124
+33% +$949K 0.15% 114
2018
Q2
$2.59M Sell
12,505
-1,185
-9% -$252K 0.1% 156
2018
Q1
$2.83M Sell
13,690
-525
-4% -$110K 0.11% 144
2017
Q4
$2.7M Sell
14,215
-4,533
-24% -$868K 0.1% 164
2017
Q3
$3.55M Buy
18,748
+1,726
+10% +$313K 0.15% 119
2017
Q2
$2.97M Buy
17,022
+1,158
+7% +$195K 0.13% 124
2017
Q1
$2.44M Buy
15,864
+1,543
+11% +$236K 0.11% 147
2016
Q4
$2.02M Sell
14,321
-1,244
-8% -$183K 0.09% 175
2016
Q3
$2.48M Sell
15,565
-911
-6% -$140K 0.12% 143
2016
Q2
$2.43M Sell
16,476
-2,304
-12% -$340K 0.12% 130
2016
Q1
$2.66M Sell
18,780
-3,324
-15% -$445K 0.14% 109
2015
Q4
$3.13M Sell
22,104
-3,390
-13% -$452K 0.15% 99
2015
Q3
$3.12M Sell
25,494
-7,425
-23% -$967K 0.18% 78
2015
Q2
$4.27M Buy
32,919
+2,389
+8% +$311K 0.18% 75
2015
Q1
$4.1M Buy
30,530
+103
+0.3% +$13.3K 0.16% 90
2014
Q4
$3.81M Buy
30,427
+5,279
+21% +$642K 0.16% 101
2014
Q3
$3.06M Buy
25,148
+4,692
+23% +$570K 0.14% 113
2014
Q2
$2.41M Sell
20,456
-2,610
-11% -$307K 0.11% 168
2014
Q1
$2.77M Buy
23,066
+4,243
+23% +$504K 0.13% 122
2013
Q4
$2.1M Buy
18,823
+1,068
+6% +$106K 0.09% 161
2013
Q3
$1.64M Buy
17,755
+1,515
+9% +$137K 0.09% 206
2013
Q2
$1.37M Buy
+16,240
New +$1.35M 0.1% 174

Other funds holding TMO

Profund Advisors's TMO Position: Q2 2026 in Review

Profund Advisors reduced its Thermo Fisher Scientific (TMO) stake by 1.5% in Q2 2026, selling an estimated $29.3K and leaving 4,138 shares worth $2.07M. The position accounts for 0.06% of the portfolio, ranked #191.

Profund Advisors first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.09M in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Profund Advisors held 4,138 shares of Thermo Fisher Scientific worth $2.07M as of Q2 2026.
  • Profund Advisors sold 61 Thermo Fisher Scientific shares in Q2 2026, an estimated $29.3K.
  • Thermo Fisher Scientific made up 0.06% of Profund Advisors's portfolio in Q2 2026, its #191 holding.
  • Profund Advisors first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
  • Profund Advisors's Thermo Fisher Scientific position peaked at $6.09M in Q4 2021.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.